Optimally preserved human tissue specimens are the backbone of cancer research for basic, clinical, translational and population scientists. The purpose of the Tissue Core (TC) is: 1. To ensure the collection and storage of well-annotated human tissues for research, and to provide investigators with access to high quality human specimens, including fresh and frozen tissues, fixed tissue, and DNA/RNA products. 2. To provide histology, immunohistochemistry and in-situ hybridization services for paraffin embedded tissue. These services, outsourced in the prior core submission, have been incorporated within the Moffitt Tissue Core Facility. 3. To manufacture tissue microarrays using our rich resource of archival material here at Moffitt Cancer Center. We have recently implemented a procedure for the transfer of all archival material no longer required for clinical care to the Tissue Core for research. These will provide a repository for the construction of tissue microarrays, a service that was also outsourced prior to this submission. The Core is administrated by Domenico Coppola, MD, and Mary E. Edgerton, MD, PhD, Scientific Directors, Tyron Hoover, MD, JD, Medical Director, and the Tissue Core Executive Committee (TCEC), a multidisciplinary committee responsible for recommending policy governing tissue release and utilization, and ensuring compliance with all appropriate regulatory bodies. On average, the Tissue Core has distributed over 1,000 tissue samples and nearly 800 nucleic acid derivatives per year to investigators. The Tissue Core (TC) future goals include implementation of standard tissue banking processes in a network of community hospitals, linking clinical outcomes to patient samples. In conjunction with the Informatics Core, TC is expanding its informatics support. There is also an ongoing effort to improve the collection, processing and storage of tissues, and to optimize the collection, processing and storage of fine needle aspirate specimens for molecular and proteomic analyses. Finally, TC is developing specialized tissue based molecular testing (FISH,C-ISH, gene polymorphism-Invader) as an adjunct to immunohistochemistry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-11
Application #
7780399
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
11
Fiscal Year
2009
Total Cost
$197,564
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Perales-Puchalt, Alfredo; Perez-Sanz, Jairo; Payne, Kyle K et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol 103:799-805
Davis, Stacy N; Govindaraju, Swapamthi; Jackson, Brittany et al. (2018) Recruitment Techniques and Strategies in a Community-Based Colorectal Cancer Screening Study of Men and Women of African Ancestry. Nurs Res 67:212-221
Martínez, Úrsula; Brandon, Thomas H; Sutton, Steven K et al. (2018) Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 27:2104-2110
Kasting, Monica L; Giuliano, Anna R; Reich, Richard R et al. (2018) Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015. Cancer Epidemiol Biomarkers Prev 27:503-513
Nelson, Ashley M; Jim, Heather S L; Small, Brent J et al. (2018) Sleep disruption among cancer patients following autologous hematopoietic cell transplantation. Bone Marrow Transplant 53:307-314
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Pidala, Joseph; Beato, Francisca; Kim, Jongphil et al. (2018) In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation. Haematologica 103:531-539
Denson, Aaron; Burke, Nancy; Wapinsky, Georgine et al. (2018) Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials. Am J Clin Oncol 41:133-139
Betts, Brian C; Bastian, David; Iamsawat, Supinya et al. (2018) Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. Proc Natl Acad Sci U S A 115:1582-1587
Hoogland, Aasha I; Lechner, Suzanne C; Gonzalez, Brian D et al. (2018) Efficacy of a Spanish-Language Self-Administered Stress Management Training intervention for Latinas undergoing chemotherapy. Psychooncology 27:1305-1311

Showing the most recent 10 out of 1254 publications